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P.s The new immunosuppressant Leflunomide appears to be a potent 
inhibitor of humoral xeno-sensitization 
J. KAlTSCHICK, K. ULRICHS, and W. MÜLLER-RuCH HOLTZ 
Success in organ transplantation between phylogenetically discordant species is primarily 
limited by the presence of natural xenophile antibodies (NXA). Therefore the aims of our 
study were (a) to further analyze the kinetics of NXA in the xenogeneic model «rat-anti -
human» and (b) to manipulate their production by the new B-Iymphocyte immunosuppressive 
drug Leflunomide (LF). Antibodies (IgG, IgM) binding to human peripheral blood Iympho-
cytes (PBL) were quantitated by immunofluorescence (FACS-analysis). Results: (1) Normal 
LEW rats contain detectable amounts of NXA against human PBL (IgM> > IgG). (2) NXA 
production strongly increases and switches from IgM to IgG after sensitizing LEW rats with 
2 x 107 human PBL (i.p.). (3) Three mg/kg LF, given from day -4 to day +10 (daily i.p.) 
suppress NXA production in sensitized LEW rats (2 x 107 human PBL on day 0) in a dose-
dependent manner. This significant suppression is maintained during the period of drug 
application. Conclusions: (I) LF appears to be very potent new immunosuppressive drug for 
prevention of NXA production after xe no gen eie sensitization. (11) Presumably LF-treatment 
for suppression of the xenograft-elicited production of NXA can be combined with the 
elimination of pre-existing NXA, thus eliminating a major barrier for xeno-transplantation. 
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P.9 Effeets of eyclosporine administration to eßt7 seid/seid 
reeonstituted with human mononuclear leukoeytes 
CHRISTOPH H. LADEL and UWE BAMBERGER 
CB17 seid/seid (seid) mice accept human peripheral blood mononuclear cells (huMNC) and 
which remain functional in the animals for about 25 weeks after transfer. It is possible to detect 
human immunoglobulins (2-3 mg/mi) in the sera of the mice subsequent to the transfer. In 
order to determine the influence of immunopharmacological agents we tested this system using 
the known immunosuppressive agent Cyclosporine A (CyA). After i.v. injection of CyA the 
serum level of human immunoglobulins show a significant decrease compared to untreated 
animals. Therefore, it seems that the huMNC transferred to seid underlie functional regulation 
and that this system is useful for studying immunopharmacological effects of drugs. 
